Comparison between Renol Polychem IPO and Spinaroo Commercial IPO.
IPO Details
Renol Polychem IPO is a SME Fixed Price IPO proposed to list at NSE SME while Spinaroo Commercial IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of Renol Polychem IPO is up to ₹24.20 Cr whereas the issue size of the Spinaroo Commercial IPO is up to ₹9.66 Cr. The final issue price of Renol Polychem IPO is ₹105.00 per share and of Spinaroo Commercial IPO is ₹51.00 per share.
Renol Polychem IPO opens on Jul 31, 2025, while Spinaroo Commercial IPO opens on Mar 28, 2025. The closing date of Renol Polychem IPO and Spinaroo Commercial IPO is Aug 04, 2025, and Apr 03, 2025, respectively.
In the Renol Polychem IPO Retail Individual Investors (RII) are offered 13,15,200 shares while in Spinaroo Commercial IPO retail investors are offered 13,15,200 shares. Qualified Institutional Buyers (QIB) are offered 2,56,800 shares in Renol Polychem IPO and 0 shares in Spinaroo Commercial IPO.